Visual Function News Today

PRIME Designation Granted Based on Phase 2 ARCHER Trial Results, which Showed Meaningful Preservation of Visual Function in Patients with Geographic Atrophy ANX007 is the First Therapeutic...

Sweden: Postnatal supplementation with enteral arachidonic acid (AA)/docosahexaenoic acid (DHA) to extremely preterm (EPT) children did not significantly alter visual acuity (VA) at 2.5 years of...

ARCHER Trial Results Presented at ASRS Further Demonstrate Preservation of Visual Function in Patients with Geographic Atrophy; Company to Engage Regulatory Agencies to Determine Optimal Path Forward ...

Idiopathic intracranial hypertension was previously considered a rare condition, however, its prevalence is increasing in parallel with obesity in patient populations.

Dr. Jason Slakter of Vitreous Retina Macula Consultants of New York is the first to administer Syfovre, a groundbreaking treatment for geographic atrophy

Showed visual function and quality-of-life benefits in patients with extrafoveal lesionsSlowed the loss of retinal pigmented epithelial and photoreceptor...

I love Christmas! Ever since I was a child, I have resonated with the sentiment in the movie, “A Christmas Story,” where the narrator, articulating

On November 1, 2022, CMS published a final rule to update the payment policies, payment rates, and other provisions for services furnished under the Medicare Outpatient Prospective...

The Centers for Medicare & Medicaid Services (CMS) on Nov. 1, 2022, released the calendar year (CY) 2023 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical...

On July 15, 2022, the Centers for Medicare & Medicaid Services (CMS) published a proposed rule to update the payment policies, payment rates, and other provisions for services furnished...